医療/診断イメージング市場：製品タイプ別（CTスキャナ、X線イメージングシステム、MRIシステム、超音波イメージングシステム、核イメージングシステム、マンモグラフィシステム）、用途別（産科と婦人科健康、整形外科と筋骨格、神経と脊椎、心臓血管と胸部、一般イメージング、乳房の健康、その他）。世界の機会分析および産業予測、2020-2030年

Medical/Diagnostic Imaging Market By Product Type (CT Scanners, X ray Imaging Systems, MRI Systems, Ultrasound Imaging Systems, Nuclear Imaging Systems, Mammography Systems), By Application (Obstetrics and Gynecology Health, Orthopedics and Musculoskeletal, Neuro and Spine, Cardiovascular and Thoracic, General Imaging, Breast Health, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

世界の医療／診断用画像処理市場は、2020年に385億1480万ドルとなり、2021年から2030年にかけて年平均成長率5.8%を記録し、2030年には688億2660万ドルに達すると予測されています。画像診断とは、正確な診断を... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年5月31日	US$5,939 シングルユーザーライセンスライセンス・価格情報・注文方法はこちら	160	英語

サマリー

世界の医療／診断用画像処理市場は、2020年に385億1480万ドルとなり、2021年から2030年にかけて年平均成長率5.8%を記録し、2030年には688億2660万ドルに達すると予測されています。
画像診断とは、正確な診断を行うために、電磁波やその他の技術を使用して体内構造の画像を作成することです。画像診断は、放射線を用いて病気の診断や治療を行う医学の一分野である放射線医学とほぼ同じ意味です。
癌や心疾患などの慢性疾患の増加は、画像診断市場の成長を牽引しています。例えば、世界保健機関（WHO）によると、がんは世界の主要な死因の1つであり、2020年には死亡者数の約6人に1人となる約1,000万人を占めると報告されています。また、医療費の増加や正確な診断のための高度な画像処理に対する需要の高まりが、医療・診断用画像処理市場の成長を促進しています。また、疾病の診断に高度な技術を利用するための研究開発活動が活発化していることも、市場の成長に寄与しています。さらに、病院数の増加や医療インフラの整備も市場の成長に寄与しています。
また、医療用画像処理システムの技術進歩や製品投入の急増も、市場の成長に寄与しています。しかし、医療用画像処理技術の高コストが市場の成長を制限すると予想されます。
画像診断市場は、製品タイプ、アプリケーション、地域によって区分されます。製品タイプ別に見ると、市場は主にMRIシステム、超音波画像システム、X線画像システム、CTスキャナー、核画像システム、マンモグラフィシステムに分類されます。MRIシステム分野は、さらにMRIアーキテクチャとMRI磁場強度に分類されます。MRIの構造は、さらにクローズドMRIシステムとオープンMRIシステムに二分されます。MRIの磁場強度は、低～中磁場システム、高磁場システム、超高磁場システム、フィールドシステムに分類されます。超音波イメージングシステムは、2Dイメージングシステム、3D＆4Dイメージングシステム、ドップラーイメージング、高密度焦点式超音波（HIFU）、体外衝撃波結石破砕術（ESWL）に分類される。X線イメージングシステムはさらに、可搬性に基づくX線イメージングシステムと技術に基づくX線イメージングシステムに分けられます。ポータビリティ・ベースのX線イメージング・システムは、据え置き型機器と携帯型機器に分類されます。テクノロジーベースのX線イメージングシステムはさらに、デジタルイメージングとアナログイメージングに分けられます。CTスキャナーは、ハイエンドスライス、ミッドエンドスライス、ローエンドスライスに区分される。核医学イメージング装置分野は、さらにPETとSPECTに分類される。地域別では、北米、欧州、アジア太平洋地域、LAMEAで分析されています。
本レポートで紹介する主要企業は、Canon Inc. (Canon Medical Systems USA, Inc.)、Carestream Health, Inc.(Hitachi Healthcare America Corporation)、Hologic, Inc.、Koninklijke Philips N.V.、Materialise NV、Planmeca OY、Siemens AGが含まれます。

ページTOPに戻る

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: MEDICAL/DIAGNOSTIC IMAGING MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 CT Scanners
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 X ray Imaging Systems
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 MRI Systems
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Ultrasound Imaging Systems
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Nuclear Imaging Systems
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Mammography Systems
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
CHAPTER 5: MEDICAL/DIAGNOSTIC IMAGING MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Obstetrics and Gynecology Health
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Orthopedics and Musculoskeletal
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Neuro and Spine
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Cardiovascular and Thoracic
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 General Imaging
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
5.7 Breast Health
5.7.1 Key market trends, growth factors and opportunities
5.7.2 Market size and forecast, by region
5.7.3 Market analysis by country
5.8 Others
5.8.1 Key market trends, growth factors and opportunities
5.8.2 Market size and forecast, by region
5.8.3 Market analysis by country
CHAPTER 6: MEDICAL/DIAGNOSTIC IMAGING MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Product Type
6.2.3 North America Market size and forecast, by Application
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Product Type
6.2.4.1.2 Market size and forecast, by Application
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Product Type
6.2.4.2.2 Market size and forecast, by Application
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Product Type
6.2.4.3.2 Market size and forecast, by Application
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Product Type
6.3.3 Europe Market size and forecast, by Application
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Product Type
6.3.4.1.2 Market size and forecast, by Application
6.3.4.2 France
6.3.4.2.1 Market size and forecast, by Product Type
6.3.4.2.2 Market size and forecast, by Application
6.3.4.3 United Kingdom
6.3.4.3.1 Market size and forecast, by Product Type
6.3.4.3.2 Market size and forecast, by Application
6.3.4.4 Rest of Europe
6.3.4.4.1 Market size and forecast, by Product Type
6.3.4.4.2 Market size and forecast, by Application
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Product Type
6.4.3 Asia-Pacific Market size and forecast, by Application
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 Japan
6.4.4.1.1 Market size and forecast, by Product Type
6.4.4.1.2 Market size and forecast, by Application
6.4.4.2 China
6.4.4.2.1 Market size and forecast, by Product Type
6.4.4.2.2 Market size and forecast, by Application
6.4.4.3 Australia
6.4.4.3.1 Market size and forecast, by Product Type
6.4.4.3.2 Market size and forecast, by Application
6.4.4.4 India
6.4.4.4.1 Market size and forecast, by Product Type
6.4.4.4.2 Market size and forecast, by Application
6.4.4.5 Rest of Asia-Pacific
6.4.4.5.1 Market size and forecast, by Product Type
6.4.4.5.2 Market size and forecast, by Application
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Product Type
6.5.3 LAMEA Market size and forecast, by Application
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Latin America
6.5.4.1.1 Market size and forecast, by Product Type
6.5.4.1.2 Market size and forecast, by Application
6.5.4.2 Middle East
6.5.4.2.1 Market size and forecast, by Product Type
6.5.4.2.2 Market size and forecast, by Application
6.5.4.3 Africa
6.5.4.3.1 Market size and forecast, by Product Type
6.5.4.3.2 Market size and forecast, by Application
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 CANON INC.
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Carestream Health, Inc
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Esaote SpA
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 General Electric Company
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Hitachi Ltd
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 Hologic, Inc.
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Koninklijke Philips N.V.
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Materialise NV
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 planmeca oy
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Siemens AG
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL MEDICAL/DIAGNOSTIC IMAGING MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 2. MEDICAL/DIAGNOSTIC IMAGING MARKET REVENUE, FOR CT SCANNERS, BY REGION , 2020-2030,($MILLION)
TABLE 3. MEDICAL/DIAGNOSTIC IMAGING MARKET CT SCANNERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. MEDICAL/DIAGNOSTIC IMAGING MARKET REVENUE, FOR X RAY IMAGING SYSTEMS, BY REGION , 2020-2030,($MILLION)
TABLE 5. MEDICAL/DIAGNOSTIC IMAGING MARKET X RAY IMAGING SYSTEMS BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. MEDICAL/DIAGNOSTIC IMAGING MARKET REVENUE, FOR MRI SYSTEMS, BY REGION , 2020-2030,($MILLION)
TABLE 7. MEDICAL/DIAGNOSTIC IMAGING MARKET MRI SYSTEMS BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. MEDICAL/DIAGNOSTIC IMAGING MARKET REVENUE, FOR ULTRASOUND IMAGING SYSTEMS, BY REGION , 2020-2030,($MILLION)
TABLE 9. MEDICAL/DIAGNOSTIC IMAGING MARKET ULTRASOUND IMAGING SYSTEMS BY COUNTRY, 2020-2030,($MILLION)
TABLE 10. MEDICAL/DIAGNOSTIC IMAGING MARKET REVENUE, FOR NUCLEAR IMAGING SYSTEMS, BY REGION , 2020-2030,($MILLION)
TABLE 11. MEDICAL/DIAGNOSTIC IMAGING MARKET NUCLEAR IMAGING SYSTEMS BY COUNTRY, 2020-2030,($MILLION)
TABLE 12. MEDICAL/DIAGNOSTIC IMAGING MARKET REVENUE, FOR MAMMOGRAPHY SYSTEMS, BY REGION , 2020-2030,($MILLION)
TABLE 13. MEDICAL/DIAGNOSTIC IMAGING MARKET MAMMOGRAPHY SYSTEMS BY COUNTRY, 2020-2030,($MILLION)
TABLE 14. GLOBAL MEDICAL/DIAGNOSTIC IMAGING MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 15. MEDICAL/DIAGNOSTIC IMAGING MARKET REVENUE, FOR OBSTETRICS AND GYNECOLOGY HEALTH, BY REGION , 2020-2030,($MILLION)
TABLE 16. MEDICAL/DIAGNOSTIC IMAGING MARKET OBSTETRICS AND GYNECOLOGY HEALTH BY COUNTRY, 2020-2030,($MILLION)
TABLE 17. MEDICAL/DIAGNOSTIC IMAGING MARKET REVENUE, FOR ORTHOPEDICS AND MUSCULOSKELETAL, BY REGION , 2020-2030,($MILLION)
TABLE 18. MEDICAL/DIAGNOSTIC IMAGING MARKET ORTHOPEDICS AND MUSCULOSKELETAL BY COUNTRY, 2020-2030,($MILLION)
TABLE 19. MEDICAL/DIAGNOSTIC IMAGING MARKET REVENUE, FOR NEURO AND SPINE, BY REGION , 2020-2030,($MILLION)
TABLE 20. MEDICAL/DIAGNOSTIC IMAGING MARKET NEURO AND SPINE BY COUNTRY, 2020-2030,($MILLION)
TABLE 21. MEDICAL/DIAGNOSTIC IMAGING MARKET REVENUE, FOR CARDIOVASCULAR AND THORACIC, BY REGION , 2020-2030,($MILLION)
TABLE 22. MEDICAL/DIAGNOSTIC IMAGING MARKET CARDIOVASCULAR AND THORACIC BY COUNTRY, 2020-2030,($MILLION)
TABLE 23. MEDICAL/DIAGNOSTIC IMAGING MARKET REVENUE, FOR GENERAL IMAGING, BY REGION , 2020-2030,($MILLION)
TABLE 24. MEDICAL/DIAGNOSTIC IMAGING MARKET GENERAL IMAGING BY COUNTRY, 2020-2030,($MILLION)
TABLE 25. MEDICAL/DIAGNOSTIC IMAGING MARKET REVENUE, FOR BREAST HEALTH, BY REGION , 2020-2030,($MILLION)
TABLE 26. MEDICAL/DIAGNOSTIC IMAGING MARKET BREAST HEALTH BY COUNTRY, 2020-2030,($MILLION)
TABLE 27. MEDICAL/DIAGNOSTIC IMAGING MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 28. MEDICAL/DIAGNOSTIC IMAGING MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 29. MEDICAL/DIAGNOSTIC IMAGING MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 30. NORTH AMERICA MEDICAL/DIAGNOSTIC IMAGING MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 31. NORTH AMERICA MEDICAL/DIAGNOSTIC IMAGING MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 32. NORTH AMERICA MEDICAL/DIAGNOSTIC IMAGING MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 33. U.S. MEDICAL/DIAGNOSTIC IMAGING MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 34. U.S. MEDICAL/DIAGNOSTIC IMAGING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 35. CANADA MEDICAL/DIAGNOSTIC IMAGING MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 36. CANADA MEDICAL/DIAGNOSTIC IMAGING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 37. MEXICO MEDICAL/DIAGNOSTIC IMAGING MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 38. MEXICO MEDICAL/DIAGNOSTIC IMAGING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 39. EUROPE MEDICAL/DIAGNOSTIC IMAGING MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 40. EUROPE MEDICAL/DIAGNOSTIC IMAGING MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 41. EUROPE MEDICAL/DIAGNOSTIC IMAGING MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 42. GERMANY MEDICAL/DIAGNOSTIC IMAGING MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 43. GERMANY MEDICAL/DIAGNOSTIC IMAGING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 44. FRANCE MEDICAL/DIAGNOSTIC IMAGING MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 45. FRANCE MEDICAL/DIAGNOSTIC IMAGING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 46. UNITED KINGDOM MEDICAL/DIAGNOSTIC IMAGING MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 47. UNITED KINGDOM MEDICAL/DIAGNOSTIC IMAGING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 48. REST OF EUROPE MEDICAL/DIAGNOSTIC IMAGING MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 49. REST OF EUROPE MEDICAL/DIAGNOSTIC IMAGING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 50. ASIA-PACIFIC MEDICAL/DIAGNOSTIC IMAGING MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 51. ASIA-PACIFIC MEDICAL/DIAGNOSTIC IMAGING MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 52. ASIA-PACIFIC MEDICAL/DIAGNOSTIC IMAGING MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 53. JAPAN MEDICAL/DIAGNOSTIC IMAGING MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 54. JAPAN MEDICAL/DIAGNOSTIC IMAGING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 55. CHINA MEDICAL/DIAGNOSTIC IMAGING MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 56. CHINA MEDICAL/DIAGNOSTIC IMAGING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 57. AUSTRALIA MEDICAL/DIAGNOSTIC IMAGING MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 58. AUSTRALIA MEDICAL/DIAGNOSTIC IMAGING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 59. INDIA MEDICAL/DIAGNOSTIC IMAGING MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 60. INDIA MEDICAL/DIAGNOSTIC IMAGING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 61. REST OF ASIA-PACIFIC MEDICAL/DIAGNOSTIC IMAGING MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 62. REST OF ASIA-PACIFIC MEDICAL/DIAGNOSTIC IMAGING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 63. LAMEA MEDICAL/DIAGNOSTIC IMAGING MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 64. LAMEA MEDICAL/DIAGNOSTIC IMAGING MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 65. LAMEA MEDICAL/DIAGNOSTIC IMAGING MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 66. LATIN AMERICA MEDICAL/DIAGNOSTIC IMAGING MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 67. LATIN AMERICA MEDICAL/DIAGNOSTIC IMAGING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 68. MIDDLE EAST MEDICAL/DIAGNOSTIC IMAGING MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 69. MIDDLE EAST MEDICAL/DIAGNOSTIC IMAGING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 70. AFRICA MEDICAL/DIAGNOSTIC IMAGING MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 71. AFRICA MEDICAL/DIAGNOSTIC IMAGING MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 72.CANON INC.: COMPANY SNAPSHOT
TABLE 73.CANON INC.: OPERATING SEGMENTS
TABLE 74.CANON INC.: PRODUCT PORTFOLIO
TABLE 75.CANON INC.: NET SALES,
TABLE 76.CANON INC.: KEY STRATERGIES
TABLE 77.CARESTREAM HEALTH, INC: COMPANY SNAPSHOT
TABLE 78.CARESTREAM HEALTH, INC: OPERATING SEGMENTS
TABLE 79.CARESTREAM HEALTH, INC: PRODUCT PORTFOLIO
TABLE 80.CARESTREAM HEALTH, INC: NET SALES,
TABLE 81.CARESTREAM HEALTH, INC: KEY STRATERGIES
TABLE 82.ESAOTE SPA: COMPANY SNAPSHOT
TABLE 83.ESAOTE SPA: OPERATING SEGMENTS
TABLE 84.ESAOTE SPA: PRODUCT PORTFOLIO
TABLE 85.ESAOTE SPA: NET SALES,
TABLE 86.ESAOTE SPA: KEY STRATERGIES
TABLE 87.GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
TABLE 88.GENERAL ELECTRIC COMPANY: OPERATING SEGMENTS
TABLE 89.GENERAL ELECTRIC COMPANY: PRODUCT PORTFOLIO
TABLE 90.GENERAL ELECTRIC COMPANY: NET SALES,
TABLE 91.GENERAL ELECTRIC COMPANY: KEY STRATERGIES
TABLE 92.HITACHI LTD: COMPANY SNAPSHOT
TABLE 93.HITACHI LTD: OPERATING SEGMENTS
TABLE 94.HITACHI LTD: PRODUCT PORTFOLIO
TABLE 95.HITACHI LTD: NET SALES,
TABLE 96.HITACHI LTD: KEY STRATERGIES
TABLE 97.HOLOGIC, INC.: COMPANY SNAPSHOT
TABLE 98.HOLOGIC, INC.: OPERATING SEGMENTS
TABLE 99.HOLOGIC, INC.: PRODUCT PORTFOLIO
TABLE 100.HOLOGIC, INC.: NET SALES,
TABLE 101.HOLOGIC, INC.: KEY STRATERGIES
TABLE 102.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 103.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 104.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 105.KONINKLIJKE PHILIPS N.V.: NET SALES,
TABLE 106.KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
TABLE 107.MATERIALISE NV: COMPANY SNAPSHOT
TABLE 108.MATERIALISE NV: OPERATING SEGMENTS
TABLE 109.MATERIALISE NV: PRODUCT PORTFOLIO
TABLE 110.MATERIALISE NV: NET SALES,
TABLE 111.MATERIALISE NV: KEY STRATERGIES
TABLE 112.PLANMECA OY: COMPANY SNAPSHOT
TABLE 113.PLANMECA OY: OPERATING SEGMENTS
TABLE 114.PLANMECA OY: PRODUCT PORTFOLIO
TABLE 115.PLANMECA OY: NET SALES,
TABLE 116.PLANMECA OY: KEY STRATERGIES
TABLE 117.SIEMENS AG: COMPANY SNAPSHOT
TABLE 118.SIEMENS AG: OPERATING SEGMENTS
TABLE 119.SIEMENS AG: PRODUCT PORTFOLIO
TABLE 120.SIEMENS AG: NET SALES,
TABLE 121.SIEMENS AG: KEY STRATERGIES

LIST OF FIGURES
FIGURE 1.MEDICAL/DIAGNOSTIC IMAGING MARKET SEGMENTATION
FIGURE 2.MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030
FIGURE 3.MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.MEDICAL/DIAGNOSTIC IMAGING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.MEDICAL/DIAGNOSTIC IMAGING MARKET,BY PRODUCT TYPE,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF CT SCANNERS MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF X RAY IMAGING SYSTEMS MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF MRI SYSTEMS MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF ULTRASOUND IMAGING SYSTEMS MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF NUCLEAR IMAGING SYSTEMS MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MAMMOGRAPHY SYSTEMS MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030(%)
FIGURE 18.MEDICAL/DIAGNOSTIC IMAGING MARKET,BY APPLICATION,2020(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF OBSTETRICS AND GYNECOLOGY HEALTH MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF ORTHOPEDICS AND MUSCULOSKELETAL MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF NEURO AND SPINE MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR AND THORACIC MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF GENERAL IMAGING MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF BREAST HEALTH MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHERS MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030(%)
FIGURE 26.MEDICAL/DIAGNOSTIC IMAGING MARKET BY REGION,2020
FIGURE 27.U.S. MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030($MILLION)
FIGURE 28.CANADA MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030($MILLION)
FIGURE 29.MEXICO MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030($MILLION)
FIGURE 30.GERMANY MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030($MILLION)
FIGURE 31.FRANCE MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030($MILLION)
FIGURE 32.UNITED KINGDOM MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030($MILLION)
FIGURE 33.REST OF EUROPE MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030($MILLION)
FIGURE 34.JAPAN MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030($MILLION)
FIGURE 35.CHINA MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030($MILLION)
FIGURE 36.AUSTRALIA MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030($MILLION)
FIGURE 37.INDIA MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030($MILLION)
FIGURE 38.REST OF ASIA-PACIFIC MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030($MILLION)
FIGURE 39.LATIN AMERICA MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030($MILLION)
FIGURE 40.MIDDLE EAST MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030($MILLION)
FIGURE 41.AFRICA MEDICAL/DIAGNOSTIC IMAGING MARKET,2020-2030($MILLION)
FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 45.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 46.COMPETITIVE DASHBOARD
FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 48.CANON INC..: NET SALES ,($MILLION)
FIGURE 49.CARESTREAM HEALTH, INC.: NET SALES ,($MILLION)
FIGURE 50.ESAOTE SPA.: NET SALES ,($MILLION)
FIGURE 51.GENERAL ELECTRIC COMPANY.: NET SALES ,($MILLION)
FIGURE 52.HITACHI LTD.: NET SALES ,($MILLION)
FIGURE 53.HOLOGIC, INC..: NET SALES ,($MILLION)
FIGURE 54.KONINKLIJKE PHILIPS N.V..: NET SALES ,($MILLION)
FIGURE 55.MATERIALISE NV.: NET SALES ,($MILLION)
FIGURE 56.PLANMECA OY.: NET SALES ,($MILLION)
FIGURE 57.SIEMENS AG.: NET SALES ,($MILLION)

ページTOPに戻る

Table of Contents

Summary

The global medical/diagnostic imaging market was valued at $38,514.8 million in 2020, and is projected to reach $68,826.6 million by 2030, registering a CAGR of 5.8% from 2021 to 2030.
Medical/diagnostic imaging is the use of electromagnetic radiation and certain other technologies to produce images of internal structures of the body for the purpose of accurate diagnosis. Diagnostic imaging is roughly equivalent to radiology, the branch of medicine that uses radiation to diagnose and treat diseases.
The increase in prevalence of chronic diseases such as cancer, cardiovascular disease globally drives the growth of medical/diagnostic imaging market. For instance, according to World Health Organization (WHO), it was reported that cancer is one of the leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, which is nearly one in six deaths. In addition, increase in healthcare expenditure and rise in demand for advanced imaging for accurate diagnosis propels the growth of medical/diagnostic imaging market. The increase in R&D activities to use the advanced technology in diagnosis of disease contributes in the growth of market. Furthermore, rise in number of hospitals and well-developed healthcare infrastructure contributes in market growth.
In addition, advancement in technology in medical imaging system and surge in product launch contribute to the growth of the medical/diagnostic imaging market. However, the high cost of medical imaging technology is expected to limit the growth of market.
The medical/diagnostic imaging market is segmented on the basis of product type, application, and region. By product type, the market is mainly categorized into MRI systems, Ultrasound imaging systems, X-ray imaging systems, CT Scanners, Nuclear imaging systems, and mammography systems. MRI systems segment is further classified into MRI architecture and MRI field strength. MRI architecture is further bifurcated into closed MRI systems and open MRI systems. MRI field strength is categorized by low to mid field systems, high field systems, very high field systems, and field systems. Ultrasound imaging systems is divided into 2D imaging systems, 3D & 4D imaging systems, Doppler imaging, high-intensity focused ultrasound (HIFU), and Extracorporeal Shock Wave Lithotripsy (ESWL). X-ray imaging systems are further divided into probability based x-ray imaging systems and technology based x-ray imaging systems. Portability based X-Ray imaging systems is categorized into stationary devices and portable devices. Technology based X-Ray imaging systems is further divided into digital imaging and analog imaging. CT scanners segment is fragmented into high end slice, mid end slice and low end slice. Nuclear imaging systems segment is further categorized into PET and SPECT. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include Canon Inc. (Canon Medical Systems USA, Inc.), Carestream Health, Inc., Esaote SpA, General Electric Company (GE Healthcare), Hitachi Ltd. (Hitachi Healthcare America Corporation), Hologic, Inc., Koninklijke Philips N.V., Materialise NV, Planmeca OY and Siemens AG.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（中枢神経系作用薬）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（neuro）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（中枢神経系作用薬）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（neuro）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?